Emergent Product Development Gaithersburg INC.
UEI CNPVCR8DK7M8 · MD · subsidiary of Emergent Biosolutions INC. · SAM.gov record ↗
$205.2M
FY2025 obligations
4
Contract awards
Sep 29, 2016
First action
Jun 25, 2026
Latest action
Obligations by agency
- Department Of Health And Human Services$205.2M
Obligations by NAICS
Monthly obligations
Dec 24
Jan 25
Apr 25
May 25
Jul 25
Aug 25
Sep 25
Feb 26
Apr 26
Jun 26
Contracts ending within 18 months (recompete watch)
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| HHSO100201600030C ↗ | EO14042 EMERGENT AV7909 ANTHRAX VACCINE | Office Of Assistant Secretary For Preparedness And Response | 541711 | $80.0M | Sep 29, 2016 | Sep 28, 2026 |
| 75N98026P00379 ↗ | HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | National Institutes Of Health | 541714 | $11K | Apr 26, 2026 | Mar 30, 2027 |
Largest awards
| PIID | Description | Agency | NAICS | Obligated | Start | End |
|---|---|---|---|---|---|---|
| 75A50119C00071 ↗ | ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM) | Office Of Assistant Secretary For Preparedness And Response | 325414 | $108.5M | Aug 29, 2019 | Aug 28, 2029 |
| HHSO100201600030C ↗ | EO14042 EMERGENT AV7909 ANTHRAX VACCINE | Office Of Assistant Secretary For Preparedness And Response | 541711 | $80.0M | Sep 29, 2016 | Sep 28, 2026 |
| 75A50123C00037 ↗ | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE ARTICLES B.1 BRIEF DESCRIPTION OF SUPPLIES AND SERVICES, B.5 ADVANCE UNDERSTANDINGS, C.1 STATEMENT OF WORK DATED DECEMBER 9, 2024, F.2 DELIVERIES, F.4 DELIVERABLES TO DELETE VENDOR MANAGED INVENTORY (VMI) | Office Of Assistant Secretary For Preparedness And Response | 541714 | $16.7M | Jul 30, 2023 | Jul 28, 2033 |
| 75N98026P00379 ↗ | HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | National Institutes Of Health | 541714 | $11K | Apr 26, 2026 | Mar 30, 2027 |